IP Library Granted Patent US 9,677,129
Granted Patent B2
US 9,677,129 · App. 14/193,393 · Granted Jun 13, 2017

Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell

Inventors: Aris N. Economides (Tarrytown, NY); Andrew J. Murphy (Croton-On-Hudson, NY); David M. Valenzuela (Yorktown Heights, NY); David Frendewey (New York, NY); George D. Yancopoulos (Yorktown Heights, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C12Q1/6827A01K67/0275C12N15/79C12N15/907A01K2217/05A01K2227/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,677,129
App. No.
14/193,393
Granted
Jun 13, 2017
Kind
B2
Abstract

A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.

Claims (11)

1. A method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse embryonic stem (ES) cell, the method comprising: (a) exposing the DNA of the mouse ES cell to a first probe and a second probe, wherein the first probe binds within the endogenous allele but not within the modified allele, and the second probe binds within a reference gene but not within the endogenous allele and not within the modified allele, wherein both probes generate a detectable signal upon binding, and wherein the reference gene is of known copy number; (b) detecting the signal from the binding of the first probe and the signal from the binding of the second probe; and (c) comparing the signal from the binding of the second probe to the signal from the binding of the first probe, and determining from the comparison a copy number of the endogenous allele.

2. The method of claim 1 , wherein the modified allele is orthologous to the endogenous allele.

3. The method of claim 2 , wherein the modified allele is a human allele orthologous to the endogenous allele.

4. The method of claim 1 , wherein the signal from the binding of the first probe is used to determine a first threshold cycle (Ct) value for the endogenous allele and the signal from the binding of the second probe is used to determine a second Ct value for the reference gene, and wherein copy number of the endogenous mouse allele is determined by comparing the first Ct value and the second Ct value.

5. The method of claim 1 , wherein the copy number of the endogenous allele is one.

6. The method of claim 1 , wherein the copy number of the endogenous allele is zero.

7. The method of claim 1 , wherein the Ct value of the second probe is the same in targeted ES cells as compared to the Ct value in non-targeted cells.

8. The method of claim 1 , wherein the modified allele comprises a regulatory element.

9. The method of claim 1 , wherein the modified allele comprises a protein-coding sequence.

10. The method of claim 9 , wherein the protein-coding sequence contains an alteration as compared to a protein-coding sequence within the endogenous allele.

11. The method of claim 10 , wherein the alteration is selected from the group consisting of a deletion, an insertion and a substitution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: ECONOMIDES, ARIS N.; MURPHY, ANDREW J.; VALENZUELA, DAVID M.; FRENDEWEY, DAVID; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 033108/0206 →
Continuity (5)
Continuation 11809473 · Jun 1, 2007
Continuation 10415440
Continuation In Part 09732234 · Dec 7, 2000
Provisional Application 60244665 · Oct 31, 2000
Related Publication 20140178879A1 · Jun 26, 2014